Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.73 |
| ▸ | THRB | P10828 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octane SCHEMBL27279068 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Methylene Chloride SCHEMBL29048529 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Methylene Chloride SCHEMBL28685517 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Heptane SCHEMBL8891016 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Heptane SCHEMBL219891 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Hexadecane SCHEMBL9757807 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Decane SCHEMBL16931705 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Heptane SCHEMBL6588316 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Heptane SCHEMBL17666832 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Heptane SCHEMBL10579117 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2197273-B1 | PROCESS FOR PREPARING R-GOSSYPOL L-PHENYLALANINOL DIENAMINE | ASCENTA THERAPEUTICS INC (US) | 2014-09-24 | — | — | EP | disclosed |
| EP-2197273-A1 | PROCESS FOR PREPARING R-GOSSYPOL L-PHENYLALANINOL DIENAMINE | Ascenta Therapeutics, Inc. (US) | 2010-06-23 | — | — | EP | disclosed |
| US-7696372-B2 | Process for preparing R-gossypol L-phenylalaninol dienamine | ASCENTA THERAPEUTICS, INC. (US) | 2010-04-13 | — | — | US | disclosed |
| WO-2009045410-A1 | PROCESS FOR PREPARING R-GOSSYPOL L-PHENYLALANINOL DIENAMINE | ASCENTA THERAPEUTICS, INC. (US) | 2009-04-09 | — | — | WO | disclosed |
| US-20090088590-A1 | Process for preparing R-gossypol L-Phenylalaninol dienamine | ASCENTA THERAPEUTICS, INC. (US) | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090088590-A1 | Process for preparing R-gossypol L-Phenylalaninol dienamine | ERAL1, PDCD5, ARL1 | TSHR 4171/4885THRB 4493/4885ALDH1A1 2281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.